Digital Biomarkers for Psoriatic Arthritis; A Qualitative Focus Group Study on Patient-Perceived Opportunities and Barriers
Journal article
De Groot P. et al, (2024), RMD Open
BE OPTIMAL & BE COMPLETE Week 16 & Week 52 Association of Disease Activity & Symptoms
Journal article
Kristensen LE. et al, (2024), Therapeutic Advances in Musculoskeletal Disease
Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial
Journal article
McInnes IB. et al, (2024), RMD Open
Breakout Session and Report Back: Collaboration of Rheumatologists and Dermatologists for the Care of Patients With Psoriatic Disease.
Journal article
Kampel Stolnicki D. et al, (2024), J Rheumatol
Safety and efficacy of bimekizumab in patients with psoriatic arthritis: 2-year results from two phase 3 studies
Journal article
Mease PJ. et al, (2024), Rheumatology and Therapy
Treatment of Early Oligoarticular Psoriatic Arthritis With Apremilast: Primary Outcomes at Week 16 From the FOREMOST Randomised Controlled Trial
Journal article
Gossec L. et al, (2024), Annals of the Rheumatic Diseases
GRAPPA 2023: Major Projects, Key Advances, and Milestones
Journal article
Ayan G. et al, (2024), The Journal of Rheumatology, jrheum.2024 - 0266
Enhanced surveillance for the detection of psoriatic arthritis in a UK primary care psoriasis population: results from the TUDOR trial
Journal article
McHugh N. et al, (2024), Rheumatology
The development and validation of a novel training infographic for the Physician Visual Analogue Scale (VAS) in Psoriatic Arthritis
Journal article
Gunawardana S. et al, (2024), Journal of Rheumatology
PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial) - a study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study.
Journal article
Brady S. et al, (2024), BMJ Open, 14
Effect of Bimekizumab on Patient-Reported Disease Impact in Patients with Psoriatic Arthritis: 1 Year Results from Two Phase 3 Studies
Journal article
Gossec L. et al, (2024), Rheumatology
Arthritis complicating inflammatory bowel disease – the future is now
Journal article
Song K. et al, (2024), The Lancet Rh
Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey
Journal article
Eder L. et al, (2024), Rheumatology and Therapy
Patient-Initiated Follow-Up
Journal article
Alveyn E. et al, (2024), The Journal of Rheumatology, jrheum.2024 - 0302
Coalition for Health and Gender Equity (CHANGE)—a protocol for a global cross-sectional survey of health and gender equity in rheumatology
Journal article
Khursheed T. et al, (2024), Rheumatology Advances in Practice, 8
A qualitative interview study of rheumatology patients’ experiences of COVID-19 shielding to explore the physical and psychological impact and identify associated support needs
Journal article
Silverthorne C. et al, (2024), BMJ Open
The protocol of a clinical effectiveness trial comparing standard step up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomised controlled trial
Journal article
WATSON M. et al, (2024), Therapeutic Advances in Musculoskeletal Disease
Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel
Journal article
COATES LC. et al, (2024), Rheumatology
Improvements in patient-reported outcomes after treatment with deucravacitinib in patients with psoriatic arthritis: Results from a phase 2 trial
Journal article
Strand V. et al, (2024), Arthritis Care and Research
Assessment of patient-physician interactions in Psoriatic Arthritis: national results of the ASSIST Study
Journal article
Perrotta FM. et al, (2024), Rheumatology and Therapy